SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,758,000 | +2.6% | 3,792,000 | 0.0% | 0.02% | -4.0% |
| Q1 2021 | $3,662,000 | +2.2% | 3,792,000 | 0.0% | 0.02% | -3.8% |
| Q4 2020 | $3,583,000 | +2.6% | 3,792,000 | 0.0% | 0.03% | -3.7% |
| Q3 2020 | $3,493,000 | +4.7% | 3,792,000 | 0.0% | 0.03% | 0.0% |
| Q2 2020 | $3,337,000 | +9.6% | 3,792,000 | 0.0% | 0.03% | 0.0% |
| Q1 2020 | $3,045,000 | -11.3% | 3,792,000 | 0.0% | 0.03% | +22.7% |
| Q4 2019 | $3,432,000 | +12.6% | 3,792,000 | +15.2% | 0.02% | +10.0% |
| Q3 2019 | $3,049,000 | -30.6% | 3,292,000 | -26.8% | 0.02% | -28.6% |
| Q2 2019 | $4,391,000 | – | 4,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 37,347,000 | $36,345,000 | 4.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 51,663,000 | $49,804,000 | 2.44% |
| Wellesley Asset Management | 19,638 | $19,107,000 | 2.29% |
| Radcliffe Capital Management, L.P. | 58,877,000 | $56,759,000 | 2.26% |
| DeepCurrents Investment Group LLC | 29,151,000 | $28,254,000 | 0.97% |
| Penn Mutual Asset Management, LLC | 675,000 | $651,000 | 0.74% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,212,000 | $6,056,000 | 0.71% |
| Sonora Investment Management, LLC | 5,775,000 | $5,568,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,802,000 | $22,095,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,405,000 | $22,701,000 | 0.19% |